Visanne · DIN 02374900 · 2 mg · tablet
Limited Use, Reason for Use code 432 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 432 required
Write on scriptReason for Use code 432 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 432
Reason for Use code 432
For the management of pelvic pain associated with endometriosis in patients for whom one or more less costly options are either ineffective or cannot be used.
Note: For example for patients who are refractory to 6 months of continuous combined oral contraceptives and/or medroxyprogesterone therapy OR have contraindications to these therapies.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Visanne · DIN 02374900
Manufacturer: Bayer Inc., Health Care Division; listing date 2012-07-27
Health Canada: Marketed since 2011-10-25 · brand VISANNE · ATC G03DB08 DIENOGEST · form Tablet · route Oral · ingredients DIENOGEST 2 MG · company Bayer inc · schedule Prescription
Ministry pays: $0.5115 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02374900)
Source record
DIN 02374900: Visanne
Raw flags: sec12=Y, sec3=Y
Item: 683200112; group id 794; item number 1934; lccId 00223; manufacturer id BAH
Source form: Tab; strength: 2mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $2.2314; ministry $0.5115
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02374900
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=86025
Interchangeable products
Aspen-Dienogest · DIN 02493055 · $0.5115
Jamp Dienogest · DIN 02498189 · $0.5115
M-Dienogest · DIN 02543613 · $0.5115
Mar-Dienogest · DIN 02551683 · $0.5115
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02374900
Shortage record checked October 6, 2026